Pure Global AI
Disease / condition

Major Depressive Disorder clinical trials

Free access to 1,198 studies10+ countriesUpdated daily209 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
1,198
Total trials
10+
Countries
10+
Sponsors
209
Recruiting
By phase
N/A546
Phase 3201
Phase 2147
Phase 4136
Phase 163
By status
Completed667
Recruiting209
Not yet recruit...113
Unknown88
Terminated58
Top countries
United States of America438
China87
Canada65
Japan48
Australia26
Top sponsors
H. Lundbeck A/S45
Massachusetts Gene...40
Eli Lilly and Comp...36
Forest Laboratorie...25
Shanghai Mental He...22
Recent trials
Latest clinical trials for Major Depressive Disorder
Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression
Biohaven Therapeutics Ltd.
NCT06419608Not yet recr...
Phase
Phase 2
Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol
Axsome Therapeutics, Inc. · United States of America
NCT06360419Recruiting
Phase
Phase 3
New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)
Brainsway · United States of America
NCT06357832Not yet recr...
Regulation of Affect and Physiology in Depression
University of Southern Califor... · United States of America
NCT06345859Recruiting
Phase
Phase 2
Standardized Assessment in Depression Treatment in Routine Psychiatric Services
Karolinska Institutet · Sweden
NCT06332261Recruitment ...
Pharmacologic Treatment Augmentation in Chronic Depression
University Hospital Tuebingen · Germany
NCT06410599Not yet recr...
Phase
Phase 2
Whole-body Hyperthermia for Depression
University of Zurich · Switzerland
NCT06323785Recruiting
Application of the Web-based Acceptance and Commitment Therapy for Depression
Gachon University · South Korea
NCT06293781Recruiting
A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder
Neurocrine Biosciences · United States of America
NCT06267846Recruiting
Phase
Phase 2
Behavioral Activation for Depression and Habitual Rumination
Ragnar Pétur Ólafsson · Iceland
NCT06322420Recruiting
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder
Sirtsei Pharmaceuticals, Inc. · United States of America
NCT06254612Recruiting
Phase
Phase 2
Clinical, Cognitive and Neural Effects of Potentiation of ECT by rTMS in Treatment-Resistant Depression
Centre Hospitalier du Rouvray
NCT06391723Not yet recr...
A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD
Gilgamesh Pharmaceuticals · United Kingdom
NCT06309277Recruiting
Phase
Phase 2
A Phase 2a Study to Evaluate the Safety and Tolerability of GM-2505 in Patients With MDD
Gilgamesh Pharmaceuticals · United Kingdom
NCT06236880Recruiting
Phase
Phase 2
Open-Label of SPN-820 in Adults With Major Depressive Disorder
Navitor Pharmaceuticals, Inc. · United States of America
NCT06235905Recruiting
Phase
Phase 2
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
Massachusetts General Hospital
NCT06247839Not yet recr...
Phase
Phase 3
Stress Management in Depressive Disorder: Resilience Training vs. Yoga: Biological, Epigenetic, and Brain Correlates
Medical University Innsbruck · Austria
NCT06229652Not yet recr...
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Axsome Therapeutics, Inc. · United States of America
NCT06223880Recruiting
Phase
Phase 4
Impact of Psychomotor Therapy on the Quality of Life in Depression
Centre Hospitalier Esquirol · France
NCT06234176Not yet recr...
Neural Circuit Effects of Ketamine in Depression
Icahn School of Medicine at Mo... · United States of America
NCT06213324Recruiting
Phase
Phase 4
About this profile

Access comprehensive clinical trial information for Major Depressive Disorder through Pure Global AI's free database. This collection includes 1,198 clinical trials across multiple phases including N/A, Phase 3, Phase 2. Currently, 209 trials are actively recruiting participants.

Research for Major Depressive Disorder is being conducted in United States of America, China, Canada and 7+ other countries. Leading sponsors include H. Lundbeck A/S and Massachusetts General Hospital. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 1,198 clinical trials studying Major Depressive Disorder, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include H. Lundbeck A/S, Massachusetts General Hospital, Eli Lilly and Company, among others.